Answers are grounded in this paper and cite their sources.
Narrative review synthesizes evidence on cardiovascular disease in end-stage kidney disease transplant candidates, suggesting risk optimization strategies.
Kidney transplantation is the treatment of choice for end-stage kidney disease (ESKD), with more favorable long-term patient and graft outcomes than those of other modalities of renal replacement therapy. The longer the duration of maintenance dialysis therapy while waiting for renal transplantation, the higher is the likelihood of developing cardiovascular and systemic complications due to the multisystem impact of ESKD. Hence, the preparation of patients who have waited for extended periods for kidney transplantation is often challenging because of coronary artery disease, peripheral arterial disease, hypertension, and diabetes mellitus. In this narrative review, we synthesized recent evidence on cardiovascular disease in ESKD transplant candidates and proposed a pragmatic, stepwise approach to cardiovascular risk assessment and optimization before kidney transplantation.
No takes yet. Share an insight, caveat, or question.
Jebur et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: